Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. 2009

Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
Shalvata Mental Health Care Center, Cognitive and Emotional Laboratory, Hod-Hasharon, Israel.

BACKGROUND Electroconvulsive therapy (ECT) is an effective alternative for pharmacotherapy in treatment-resistant depressive patients, but the side effects limit its use. Transcranial magnetic stimulation (TMS) has been proposed as a refined alternative, but most studies do not indicate that TMS is as effective as ECT for severe depression. OBJECTIVE We propose that the limited effectiveness of standard TMS resides in its superficial effect on the cortex, although much of the pathophysiology of depression is associated with deeper and larger brain regions implicated in the reward system. Herein, we tested the effectiveness and safety of a novel TMS coil, the "H-coil," which enables direct stimulation of deeper brain regions, at the expense of focality. METHODS We have studied the antidepressant and cognitive effects induced by 4 weeks of high-frequency (20 Hz) repeated deep TMS (DTMS) over the prefrontal cortex (PFC) of 65 medication-free depressive patients, who have failed to benefit from prior medications. Patients were randomly assigned to various treatment configurations, differing in stimulation intensity and laterality. Effects were assessed by the 24-item Hamilton depression rating scale (HDRS-24) and several secondary outcome measures. RESULTS A significant improvement in HDRS scores was found when high, but not low, stimulation intensity was used. Several cognitive improvements were evident, and no treatment-related serious adverse events were observed. CONCLUSIONS DTMS over the PFC was found safe and effective in alleviating depression. The results accentuate the significance of deep, high-intensity stimulation over low, and serve as the first study to indicate the potential of DTMS in psychiatric and neurologic disorders.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
February 2011, Journal of affective disorders,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
January 2018, Frontiers in psychiatry,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
January 2007, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
June 2016, Experimental brain research,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
January 2017, Brain stimulation,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
May 2021, The European journal of neuroscience,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
December 2005, Experimental neurology,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
January 2010, Biological psychiatry,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
May 2023, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Yechiel Levkovitz, and Eiran V Harel, and Yiftach Roth, and Yoram Braw, and Dana Most, and Leor N Katz, and Aharon Sheer, and Roman Gersner, and Abraham Zangen
September 2009, Experimental neurology,
Copied contents to your clipboard!